Group 1 - The CEO of the company, Jan Jing, increased his stake in Hong Kong Xinda (09930) by purchasing 500,000 shares at a price of HKD 1.398 per share, totaling HKD 699,000 [1] - After the purchase, the CEO's total shareholding is approximately 15.9282 million shares, representing a holding percentage of 0.49% [1]

Group 1 - The latest shareholder equity disclosure for Yuan Da Pharmaceutical (00512) and Hongxin Jianda (09930) was conducted on August 25, 2025 [1] - Yuan Da Pharmaceutical saw an increase in shares held by Zhou Chao from 407,000 shares to 452,500 shares, maintaining a holding percentage of 0.01% [2] - Hongxin Jianda experienced an increase in shares held by Zhan Jing from 15,428,200 shares to 15,928,200 shares, with a holding percentage of 0.49% [2]

Group 1 - The CEO of the company, Jan Jing, increased his stake in Hongxin Jianda (09930) by purchasing 300,000 shares at a price of HKD 1.317 per share, totaling HKD 395,100 [1] - After the purchase, the CEO's total shareholding is approximately 15,428,200 shares, representing a holding percentage of 0.48% [1]

智通财经APP获悉，香港联交所最新资料显示，8月20日，首席执行官詹静增持宏信建发(09930)30万 股，每股作价1.317港元，总金额为39.51万港元。增持后最新持股数目约为1542.82万股，最新持股比例 为0.48%。 ...

Core Viewpoint - The company, MacroLink Development (09930), announced that its Executive Director and CEO, Mr. Zhan Jing, purchased 1.666 million shares of the company's ordinary stock from August 18 to August 22, 2025, representing approximately 0.05% of the total issued shares [1] Group 1 - Mr. Zhan Jing expressed confidence in the future development prospects of the group [1] - The CEO does not rule out the possibility of further increasing his shareholding at an appropriate time, subject to applicable laws and regulations [1]

Core Viewpoint - The company, Hongxin Jianda (09930.HK), announced that its Executive Director and CEO, Mr. Zhan Jing, purchased 1,666,000 shares of the company's ordinary stock in the open market, representing approximately 0.05% of the total issued shares, indicating confidence in the company's future development prospects [1] Group 1 - Mr. Zhan Jing's share purchase occurred between August 18 and August 22, 2025 [1] - The CEO expressed a strong belief in the company's future and does not rule out the possibility of further increasing his shareholding at an appropriate time, subject to applicable laws and regulations [1]

据詹静先生表示，彼对集团的未来发展前景充满信心，不排除考虑于适当时机在适用法律及法规的规限 下进一步增持公司股份的可能性。 智通财经APP讯，宏信建发(09930)公布，公司执行董事兼首席执行官詹静先生自2025年8月18日至2025 年8月22日以自有资金于公开市场交易中购入166.6万股公司普通股，占已发行股份总数的约 0.05%。 ...

宏信建設發展有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 HORIZON CONSTRUCTION DEVELOPMENT LIMITED （於開曼群島註冊成立的有限公司） （股份代號：9930） 自願公告 董事增持股份 本公告乃由宏信建設發展有限公司（「本公司」，連同其附屬公司統稱「本集團」）自 願作出。 本公司董事會（「董事會」）獲本公司執行董事兼首席執行官詹靜先生(「詹先生」) 告知，自二零二五年八月十八日至二零二五年八月二十二日，彼以自有資金於公 開市場交易中購入1,666,000股本公司普通股（「股份」），佔已發行股份總數的約 0.05%。 據詹先生表示，彼對本集團的未來發展前景充滿信心，不排除考慮於適當時機在 適用法律及法規的規限下進一步增持本公司股份的可能性。 根據本公司可公開獲得的資料及就董事會於作出一切合理查詢後所知，於上述股 份增持後及於本公告日期，本公司已繼續維持香港聯合交易所有限公司規定的已 發行股份的最低公眾持股 ...

Group 1 - The core point of the news is that the CEO of Hongxin Jianfa, Zhan Jing, has increased his shareholding in the company by purchasing 1.166 million shares at an average price ranging from HKD 1.2936 to HKD 1.317, totaling approximately HKD 1.5154 million [1] - Following the purchase, Zhan Jing's total shareholding increased to 15,428,186 shares, raising his ownership percentage from 0.44% to 0.48% [1]

Group 1 - The company,宏信建发, has resolved to grant up to 9.58 million options to certain participants under its share option plan adopted on June 4, 2024, with an exercise price of HKD 1.34 per option and a 10-year exercise period [1] Group 2 - The total number of ordinary shares that can be subscribed through the options granted is also 9.58 million [1]